fewer admissions to the neonatal intensive care unit for hypoglycaemia. This would be expected to reduce overall treatment costs, but this has not been specifically determined.
Stillbirth Foundation, Sydney, Australia Email: adrienne.gordon@sydney.edu.au Background: Maternal age, weight and ethnicity are known risk factors for stillbirth. Previous studies have assessed these risk factors within populations in one country. We explored these risk factors across different countries using data from the Cribss IPD study.
Methods: The Cribss IPD comprises four case-control studies investigating modifiable risk factors for late stillbirth (≥28 weeks) and includes comprehensive maternal data (PROSPERO registration: CRD42017047703). Earliest maternal BMI in pregnancy was categorised into five groups. Maternal age was categorised into 6 groups from <20 to >40 in 5 year epochs. Ethnicity was categorised as White, Black, South Asian, South East and East Asian, M aori, Pacific and other. Univariate and multivariate analyses were performed.
Results: There was a dose-response relationship between maternal BMI and late stillbirth risk. Compared to normal BMI, women who were overweight or obese had increased late stillbirth risk. Background: Mothers of preterm infants often struggle to produce enough breast milk to meet the nutritional needs of their infant. Galactagogues such as domperidone are often prescribed to increase breast milk supply, but evidence supporting their role in clinical practice is uncertain. Therefore, the aim was to perform a systematic review to evaluate the efficacy and safety of domperidone for increasing breast milk volume in mothers expressing breast milk for their preterm infants.
Methods: Medline, Embase, and Web of Science were searched without language restrictions, from first publication until January 2017. Bibliographies of articles and reviews were hand searched for additional reports. We included RCTs that compared domperidone with placebo in mothers of preterm infants (<37 weeks gestation) experiencing insufficient milk supply. Two review authors independently assessed studies for inclusion, extracted data, and evaluated study quality. Difference in breast milk volume, and adverse events, were combined using fixed effects meta-analysis.
Results Background: Ketones can provide alternative cerebral fuel when glucose supply is limited. Breast-fed babies are reported to have higher blood ketone concentrations than formula fed babies, but little else is known about the factors that influence ketone concentrations. We explored the factors associated with higher blood β-hydroxybutyrate (BHB) concentrations in latepreterm and term babies.
Methods: Eligible babies were admitted to the NICU, 35-42 weeks gestation, orally fed, and ≤10 days old. Blood was taken at the same time as other clinical samples and analysed using the Randox enzymatic kit (Abacus ALS, Auckland, New Zealand), which reported undetectable levels as <0.1mmol/L. Admission reasons were categorised as respiratory, hypoglycaemia, feeding difficulties, jaundice, and preterm. Logistic regression was used to determine odds of having a higher BHB concentration, defined as above the median value of detectable concentrations (>0.2mM).
Results: Babies (n=142) had a median (range) birthweight 2770 (1721-4730) grams and gestation 37 (35-42) weeks. Blood samples were analysed at 4.7 (0.1 to 10.2) days, with 90 (63%) reported as undetectable, 26 (18%) between 0.1 and 0.2mM, and 26 (18%) ≥0.2mM. On multivariate analysis, the best predictors of higher BHB concentrations (pseudo R 2 =0.42) were an admission diagnosis of poor feeding and sampling within 6 hours (OR, 95%CI: 391.6, 25.8 to 5929), age <4 days (52.2, 5.9 to 462.9), and no formula feeding (5.2, 1.5 to 17.8).
Conclusions: Higher BHB concentrations are found in breastfed babies experiencing feeding difficulties. It is unclear whether breast feeding itself or associated starvation contributes to ketonaemia in these babies. Background: Ketones can be useful cerebral fuels when glucose availability is limited. It would be useful to measure ketone concentrations at the cotside. We sought to determine if β-hydroxybutyrate (BHB) concentrations could be accurately measured on a StatStrip™ point-of-care analyser compared with the gold standard laboratory method, using hydroxybutyrate dehydrogenase analysis.
POINT-OF-CARE ANALYSIS OF BETA-HYDROXYBUTYRATE CONCENTRATIONS IN BABIES IS
Methods: Eligible babies were 35-42 weeks gestation, orally fed, ≥10 days old, and admitted to NICU. Babies had additional blood taken once at the time sampling for clinical reasons. Blood was immediately analysed using the StatStrip™ (Nova Biomedical, MA, USA) and sent to the laboratory for analysis.
Results: Babies (n=142), were median (range) birthweight of 2770 (1721 to 4730) g, gestation 37 (35-42) weeks and 4.4 (0.1 to 10.2) days old. BHB was undetectable by both analysers in 59 samples (42%). The mean (SD; 95% (CI)) difference between methods was 0.00 mM (0.18; -0.56 to -0.34 mM) for all samples, and 0.10mM (0.22; -0.66 to 0.26 mM) if both analysers reported detectable values (n=43). At higher concentrations BHB concentrations from the StatStrip™ were lower than from the laboratory. On receiver operating characteristic analysis, maximum accuracy was observed at a laboratory BHB concentration of 0.4mM where a StatStrip™ BHB concentration of ≥ 0.4mM had a sensitivity of 93 % (95%CI: 68-100) and specificity of 97 % (95%CI: 92 -99), area under the ROC curve =0.98.
Conclusions: The StatStrip™ point-of-care analyser is reliable when the BHB concentrations are low. Concentrations >0.4 mM are accurately predicted, but the exact concentration requires laboratory confirmation. Background: Our previous research demonstrated high rates of inadequate prenatal care (PC) among women in inner-city Winnipeg and identified barriers to use of PC. Building on these findings, service providers, policy makers, and researchers collaborated to develop the Partners in Inner-city Integrated Prenatal Care (PIIPC) Project with the goal of reducing inequities in use of PC. The objective of this quantitative component of the larger mixed-methods study was to compare use of PC by PIIPC participants to a comparison group.
EVALUATION OF THE PARTNERS IN INNER-CITY
Methods: A descriptive comparative design was used. Data were collected from chart reviews of 198 women participating in PIIPC from 2012-2015, and questionnaires were administered to 101 of these women. The retrospective comparison group consisted of 202 women with inadequate PC living in the same inner-city neighbourhoods who received usual PC prior to implementation of PIIPC.
Results: The majority of women in both PIIPC and comparison group were single, low income, and Indigenous, with low education and high rates of substance use. Based on chart reviews, 83.4% of PIIPC clients had 4 or more PC visits compared to 24.9% of the comparison group, and the preterm birth rate was lower in PIIPC group (11.1%) than comparison group (14.4%). Based on questionnaires, 61.4% of PIIPC clients
